Dodecane as exhaled biomarker for exercise-induced asthma in children

Agnieszka Blanchet - Smolinska; Max Allsworth; M.P. van der Schee; Tilly Woodland

Dodecane as exhaled biomarker for exercise-induced asthma in children

Agnieszka Blanchet - Smolinska (Inventor), Max Allsworth^* (Inventor), M.P. van der Schee (Inventor), Tilly Woodland (Inventor)

^*Corresponding author for this work

Research output: Patent

Abstract

The invention relates to methods for predicting the response of a subject suffering from asthma or a respiratory disorder to a therapy comprising a Th2 pathway modulator and a device for use in such methods.

Original language	English
Patent number	US20220341911A1
IPC	G01N33/497,A61B 5/08 2006.1,G01N 33/68 2006.1
Filing date	1/10/20
Publication status	Published - 27 Oct 2022

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021064400

Cite this

@misc{5af7b94485064f9da91894f83d709f8a,

title = "Dodecane as exhaled biomarker for exercise-induced asthma in children",

abstract = "The invention relates to methods for predicting the response of a subject suffering from asthma or a respiratory disorder to a therapy comprising a Th2 pathway modulator and a device for use in such methods.",

author = "{Blanchet - Smolinska}, Agnieszka and Max Allsworth and {van der Schee}, M.P. and Tilly Woodland",

year = "2022",

month = oct,

day = "27",

language = "English",

type = "Patent",

note = "US20220341911A1; G01N33/497,A61B 5/08 2006.1,G01N 33/68 2006.1",

}

TY - PAT

T1 - Dodecane as exhaled biomarker for exercise-induced asthma in children

AU - Blanchet - Smolinska, Agnieszka

AU - Allsworth, Max

AU - van der Schee, M.P.

AU - Woodland, Tilly

PY - 2022/10/27

Y1 - 2022/10/27

N2 - The invention relates to methods for predicting the response of a subject suffering from asthma or a respiratory disorder to a therapy comprising a Th2 pathway modulator and a device for use in such methods.

AB - The invention relates to methods for predicting the response of a subject suffering from asthma or a respiratory disorder to a therapy comprising a Th2 pathway modulator and a device for use in such methods.

M3 - Patent

M1 - US20220341911A1

Y2 - 2020/10/01

ER -

Dodecane as exhaled biomarker for exercise-induced asthma in children

Abstract

Access to Document

Fingerprint

Cite this